Skip to main content
Top
Published in: Medical Oncology 2/2011

01-06-2011 | Original Paper

Relationships between levels of CXCR4 and VEGF and blood-borne metastasis and survival in patients with osteosarcoma

Authors: Feng Lin, Shui-er Zheng, Zan Shen, Li-na Tang, Ping Chen, Yuan-jue Sun, Hui Zhao, Yang Yao

Published in: Medical Oncology | Issue 2/2011

Login to get access

Abstract

The present study was designed to determine whether the expression of chemokine receptor CXCR4 and vascular endothelial growth factor (VEGF) is correlated with the extent of metastasis and the survival of patients with osteosarcoma. Using tissue microarrays, we analyzed the expression of CXCR4 and VEGF in tumor tissues collected from 56 patients with osteosarcoma. A two-year follow-up was performed to evaluate tumor metastatic behavior and the overall survival of the patients. There was a significant correlation between the expression of CXCR4 and the expression of VEGF in tumor tissues of these patients (P = 0.002). Univariate analysis revealed that expression of these proteins was correlated with clinical stage, but not age, gender, or serum alkaline phosphatase levels. The patients with tumors expressing CXCR4 and VEGF had worse overall survival rates compared with the patients with tumors that did not express CXCR4 (P = 0.03) or VEGF (P = 0.04). These data indicate that CXCR4 and VEGF expression is highly correlated with metastatic progression in patients with osteosarcoma and had predictive value for the metastasis and survival of osteosarcoma patients.
Literature
1.
go back to reference Bentzen SM. Prognostic factor studies in oncology: osteosarcoma as a clinical example. Int J Radiat Oncol Biol Phys. 2001;49:513–8.PubMedCrossRef Bentzen SM. Prognostic factor studies in oncology: osteosarcoma as a clinical example. Int J Radiat Oncol Biol Phys. 2001;49:513–8.PubMedCrossRef
2.
go back to reference Yang SY, Yu H, Krygier JE, Wooley PH, Mott MP. High VEGF with rapid growth and early metastasis in a mouse osteosarcoma model. Sarcoma. 2007;2007:95628.PubMedCrossRef Yang SY, Yu H, Krygier JE, Wooley PH, Mott MP. High VEGF with rapid growth and early metastasis in a mouse osteosarcoma model. Sarcoma. 2007;2007:95628.PubMedCrossRef
4.
go back to reference Mongan JP, Fadul CE, Cole BF, Zaki BI, Suriawinata AA, Ripple GH, et al. Brain metastases from colorectal cancer: risk factors, incidence, and the possible role of chemokines. Clin Colorectal Cancer. 2009;8:100–5.CrossRef Mongan JP, Fadul CE, Cole BF, Zaki BI, Suriawinata AA, Ripple GH, et al. Brain metastases from colorectal cancer: risk factors, incidence, and the possible role of chemokines. Clin Colorectal Cancer. 2009;8:100–5.CrossRef
5.
go back to reference Scotton CJ, Wilson JL, Scott K, Stamp G, Wilbanks GD, Fricker S, et al. Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer. Cancer Res. 2002;62:5930–8.PubMed Scotton CJ, Wilson JL, Scott K, Stamp G, Wilbanks GD, Fricker S, et al. Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer. Cancer Res. 2002;62:5930–8.PubMed
6.
go back to reference Balkwill F. The significance of cancer cell expression of the chemokine receptor CXCR4. Semin Cancer Biol. 2004;14:171–9.PubMedCrossRef Balkwill F. The significance of cancer cell expression of the chemokine receptor CXCR4. Semin Cancer Biol. 2004;14:171–9.PubMedCrossRef
8.
go back to reference Wagner PL, Hyjek E, Vazquez MF, Meherally D, Liu YF, Chadwick PA, et al. CXCL12 and CXCR4 in adenocarcinoma of the lung: association with metastasis and survival. J Thorac Cardiovasc Surg. 2009;137:615–21.PubMedCrossRef Wagner PL, Hyjek E, Vazquez MF, Meherally D, Liu YF, Chadwick PA, et al. CXCL12 and CXCR4 in adenocarcinoma of the lung: association with metastasis and survival. J Thorac Cardiovasc Surg. 2009;137:615–21.PubMedCrossRef
9.
go back to reference Yang YC, Lee ZY, Wu CC, Chen TC, Chang CL, Chen CP. CXCR4 expression is associated with pelvic lymph node metastasis in cervical adenocarcinoma. Int J Gynecol Cancer. 2007;17:676–86.PubMedCrossRef Yang YC, Lee ZY, Wu CC, Chen TC, Chang CL, Chen CP. CXCR4 expression is associated with pelvic lymph node metastasis in cervical adenocarcinoma. Int J Gynecol Cancer. 2007;17:676–86.PubMedCrossRef
10.
go back to reference Liang XL. Fundamentals and techniques of pathology. Beijing: Military Medical Publishing Co; 2003. p. 195–7. Liang XL. Fundamentals and techniques of pathology. Beijing: Military Medical Publishing Co; 2003. p. 195–7.
12.
go back to reference Tian X, Song S, Wu J, Meng L, Dong Z, Shou C. Vascular endothelial growth factor acting as an autocrine growth factor for human gastric adenocarcinoma cell MGC803. Biochem Biophys Res Commun. 2001;286:505–12.PubMedCrossRef Tian X, Song S, Wu J, Meng L, Dong Z, Shou C. Vascular endothelial growth factor acting as an autocrine growth factor for human gastric adenocarcinoma cell MGC803. Biochem Biophys Res Commun. 2001;286:505–12.PubMedCrossRef
13.
go back to reference Furudoi A, Tanaka S, Haruma K, Kitadai Y, Yoshihara M, Chayama K, et al. Clincal significance of vascular endothelial growth factor C expression and angiogenesis at the deepest invasive site of advanced colorectal carcinoma. Oncology. 2002;62:157–66.PubMedCrossRef Furudoi A, Tanaka S, Haruma K, Kitadai Y, Yoshihara M, Chayama K, et al. Clincal significance of vascular endothelial growth factor C expression and angiogenesis at the deepest invasive site of advanced colorectal carcinoma. Oncology. 2002;62:157–66.PubMedCrossRef
14.
go back to reference Kitadai Y, Amioka T, Haruma K, Tanaka S, Yoshihara M, Sumii K, et al. Clinicopathological significance of vascular endothelial growth factor (VEGF)-C in human esophageal squamous cell carcinomas. Int J Cancer. 2001;93:662–6.PubMedCrossRef Kitadai Y, Amioka T, Haruma K, Tanaka S, Yoshihara M, Sumii K, et al. Clinicopathological significance of vascular endothelial growth factor (VEGF)-C in human esophageal squamous cell carcinomas. Int J Cancer. 2001;93:662–6.PubMedCrossRef
15.
go back to reference Liang Z, Brooks J, Willard M, Liang K, Yoon Y, Kang S, et al. CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway. Biochem Biophys Res Commun. 2007;359:716–22.PubMedCrossRef Liang Z, Brooks J, Willard M, Liang K, Yoon Y, Kang S, et al. CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway. Biochem Biophys Res Commun. 2007;359:716–22.PubMedCrossRef
16.
go back to reference Bachelder RE, Wendt MA, Mercurio AM. Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4. Cancer Res. 2002;62:7203–6.PubMed Bachelder RE, Wendt MA, Mercurio AM. Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4. Cancer Res. 2002;62:7203–6.PubMed
17.
go back to reference Oda Yoshinao, Yamoto Hidetake, Tamiya Sadafumi, Matsuda S, Tanaka K, Yokoyama R, et al. CXCR4 and VEGF expression in the primary site and the metastatic site of human osteosarcoma: analysis within a group of patients, all of whom developed lung metastasis. Mod Pathol. 2006;19:738–45.PubMedCrossRef Oda Yoshinao, Yamoto Hidetake, Tamiya Sadafumi, Matsuda S, Tanaka K, Yokoyama R, et al. CXCR4 and VEGF expression in the primary site and the metastatic site of human osteosarcoma: analysis within a group of patients, all of whom developed lung metastasis. Mod Pathol. 2006;19:738–45.PubMedCrossRef
18.
go back to reference George W, Sledge JR. Vascular endothelial growth factor in breast cancer: biologic and therapeutic aspects. Semin-Oncol. 2002;29:104–10. George W, Sledge JR. Vascular endothelial growth factor in breast cancer: biologic and therapeutic aspects. Semin-Oncol. 2002;29:104–10.
Metadata
Title
Relationships between levels of CXCR4 and VEGF and blood-borne metastasis and survival in patients with osteosarcoma
Authors
Feng Lin
Shui-er Zheng
Zan Shen
Li-na Tang
Ping Chen
Yuan-jue Sun
Hui Zhao
Yang Yao
Publication date
01-06-2011
Publisher
Springer US
Published in
Medical Oncology / Issue 2/2011
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-010-9493-4

Other articles of this Issue 2/2011

Medical Oncology 2/2011 Go to the issue